X0708 D LIVE 0001751912 NERVGEN PHARMA CORP. SUITE 1703 - 595 BURRARD STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V7X 1J1 (604) 488-5421 BRITISH COLUMBIA, CANADA None None Corporation true 2017 Bill Radvak Suite 1703 - 595 Burrard Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1J1 Director Brian Bayley Suite 1703 - 595 Burrard Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1J1 Director Michael Abrams Suite 1703 - 595 Burrard Street Vanouver A1 BRITISH COLUMBIA, CANADA V7X 1J1 Director Harold Punnett Suite 1703 - 595 Burrard Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1J1 Director Paul Brennan Suite 1703 - 595 Burrard Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1J1 Director Executive Officer Randall Kaye Suite 1703 - 595 Burrard Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1J1 Director William Adams Suite 1703 - 595 Burrard Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1J1 Executive Officer Daniel Mikol Suite 1703 - 595 Burrard Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1J1 Executive Officer Glenn Ives Suite 1703 - 595 Burrard Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1J1 Director Krista McKerracher Suite 1703 - 595 Burrard Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1J1 Director Other Decline to Disclose 06b false 2021-11-29 true true true true Units consist of one common share and one-half common share purchase warrant, each whole warrant exercisable at CAD$3.20 per share until November 29, 2023. false 0 1052930 651815 401115 Total amount remaining to be sold represents the maximum potential exercise price of warrants. Subscriptions paid in Canadian currency converted to US dollars at CAD$1.2621= USD$1.00. false 17 0 0 0 false NERVGEN PHARMA CORP. /s/ William Adams William Adams CFO 2021-12-08